Haemonetics Corp
SWB:HAZ

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
SWB:HAZ
Watchlist
Price: 72.5 EUR -2.68% Market Closed
Market Cap: 2.3B EUR
Have any thoughts about
Haemonetics Corp?
Write Note

Wall Street
Price Targets

HAZ Price Targets Summary
Haemonetics Corp

Wall Street analysts forecast HAZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HAZ is 105.95 EUR with a low forecast of 80.48 EUR and a high forecast of 123.04 EUR.

Lowest
Price Target
80.48 EUR
11% Upside
Average
Price Target
105.95 EUR
46% Upside
Highest
Price Target
123.04 EUR
70% Upside
Haemonetics Corp Competitors:
Price Targets
BVS
Bioventus Inc
40% Upside
6929
OrbusNeich Medical Group Holdings Ltd
30% Upside
NAN
Nanosonics Ltd
13% Upside
AP4
Riverstone Holdings Ltd
7% Upside
ANN
Ansell Ltd
4% Downside
6491
Pegavision Corp
33% Upside
FIGS
Figs Inc
2% Upside

Revenue
Forecast

Revenue Estimate
Haemonetics Corp

For the last 8 years the compound annual growth rate for Haemonetics Corp's revenue is 5%. The projected CAGR for the next 3 years is 7%.

5%
Past Growth
7%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Haemonetics Corp

For the last 8 years the compound annual growth rate for Haemonetics Corp's operating income is 22%. The projected CAGR for the next 3 years is 26%.

22%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Net Income
Forecast

Net Income Estimate
Haemonetics Corp

The compound annual growth rate of Haemonetics Corp's net income for the next 3 years is 38%.

N/A
Past Growth
38%
Estimated Growth
Estimates Accuracy
-52%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HAZ's stock price target?
Price Target
105.95 EUR

According to Wall Street analysts, the average 1-year price target for HAZ is 105.95 EUR with a low forecast of 80.48 EUR and a high forecast of 123.04 EUR.

What is Haemonetics Corp's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Haemonetics Corp's revenue is 5%. The projected CAGR for the next 3 years is 7%.

What is Haemonetics Corp's Operating Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Haemonetics Corp's operating income is 22%. The projected CAGR for the next 3 years is 26%.

What is Haemonetics Corp's Net Income forecast?
Projected CAGR
38%

The compound annual growth rate of Haemonetics Corp's net income for the next 3 years is 38%.

Back to Top